Endometriosis: New Genetic Approaches and Therapy
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Endometriosis is a relatively common condition in women of reproductive age and is associated with considerable morbidity. Despite an extensive literature describing its multiple clinical manifestations, their management, and many aspects of the biology of endometriotic lesions, the pathophysiological mechanisms involved remain poorly understood. A genetic component in endometriosis is now recognized, and several groups have taken up the challenge of using genetic techniques to identify the aberrant molecular and cellular mechanisms in endometriosis with the intention of providing much-needed insights that might, in turn, lead to new therapies. The techniques that have been applied include expression profiling, tumor genetic studies, functional candidate gene studies, and linkage studies that can adopt a hypothesis-free approach. This review describes the current status of these studies and explores the prospects for new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696 · cited 1×
“investigated differentially expressed genes in endometrium obtained during the window of implantation from women with without endometriosis using Affymetrix microarrays (15).”
MethodAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 1×
“The application builds on the evidence that aromatase is aberrantly expressed in endometriotic tissue (50).”
BackgroundRier, S. (1993) · Fundamental and Applied Toxicology · doi:10.1006/faat.1993.1119 · Cited by 502
Heritable aspects of endometriosis
Simpson, J. L., Elias, S., Malinak, L. R., & Buttram, V. C. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90917-5 · Cited by 468
Genetic influences on endometriosis in an Australian twin sample
Treloar, S. A., O’Connor, D. T., O’Connor, V. M., & Martin, N. G. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00540-8 · Cited by 353
Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30
Jones, G. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01433-8 · Cited by 334 · cited 1×
“It is a common disease with a marked effect on quality of life (3), but the kind of progress made during the past 30 years in developing new diagnostic and therapeutic strategies in so many other conditions has not occurred in endometriosis.”
BackgroundZeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308 · cited 1×
“Conversely, expression of 17β-hydroxysteroid dehydrogenase (17β-HSD) type 2, which inactivates conversion of estradiol to estrone, is reduced in endometriotic tissue (52).”
BackgroundWhat makes a good case–control study?
Zondervan, K. T., Cardon, L. R., & Kennedy, S. H. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1415 · Cited by 271
Self-citation
Cited by
Guo, S.-W. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap064 · Cited by 328
“Finally, it has been regarded as a genetic disease (Simpson et al., 2003; Barlow and Kennedy, 2005), due, apparently, to its reported familial aggregation.”
BackgroundOral contraceptives for pain associated with endometriosis
Brown, J., Crawford, T. J., Datta, S., & Prentice, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001019.pub3 · Cited by 199
Oral contraceptives for pain associated with endometriosis
Davis, L.-J., Kennedy, S. S., Moore, J., & Prentice, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001019.pub2 · Cited by 65
Self-citationGenetics of endometriosis: current status and prospects
Vigano, P. (2007) · Frontiers in Bioscience · doi:10.2741/2308 · Cited by 62
“Evidence from genetic epidemiology of endometriosis strongly suggests that the disease is inherited as a complex genetic trait in which the phenotype results from interactions among allelic variants in several susceptibility genes, and from interactions between those genes and environmental factors (11).”
BackgroundNew candidate genes associated to endometriosis
Christofolini, D. M., Mafra, F. A., Catto, M. C., Bianco, B., & Barbosa, C. P. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1499090 · Cited by 19
“The characteristic symptoms of this disease are dysmenorrhea, dyspareunia, chronic pelvic pain, menstrual irregularities and infertility [5].”
Background
Metadata
- Authors
- Barlow, D. H., & Kennedy, S.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 2005-02-01
- Volume
- 56
- Issue
- 1
- Pages
- 345-356
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2165257778
- Cited by
- 64
- References
- 19
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endometriosis: New Genetic Approaches and Therapy. https://app.cochat.ai/papers/10.1146/annurev.med.55.091902.103805
- The paper
- Barlow, D. H., & Kennedy, S. (2005). Endometriosis: New Genetic Approaches and Therapy. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.55.091902.103805
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.